TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm | ACS Chemical Biology
Mutational processes shape the landscape of TP53 mutations in human cancer | Nature Genetics
A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer - Frontiers
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis | Cell Death Discovery
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options - ScienceDirect
Frontiers | Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties | Science Translational Medicine
Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome: Cell
Survival of patients with p53 mutations in the DNA-binding motifs... | Download Scientific Diagram
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines | PNAS
Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma | NEJM
Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers - ScienceDirect
TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors - Kim - 2023 - Cancer Medicine - Wiley Online Library
TP53 mutation spectrum in primary colorectal cancers. a Proportion of... | Download Scientific Diagram
Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
IJMS | Free Full-Text | Do Mutations Turn p53 into an Oncogene?
Mutant p53 elicits context-dependent pro-tumorigenic phenotypes | Oncogene
Probability Distributions of p53 Mutations and Their Corresponding Shannon Entropies in Different Cancer Cell Types | SpringerLink
LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
Prognostic value of TP53 mutation location in breast cancer | CMAR
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling | PNAS
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
